Postoperative Pain Relief in Children: Comparing Caudal Bupivacaine Alone Versus Bupivacaine With Dexmedetomidine for Infra-Umbilical Surgeries Under General Anesthesia
Comparison of Post-Operative Analgesia With Bupivacaine Alone Versus Bupivacaine and Dexmedetomidine, in Caudal Block for Infra-Umbilical Surgeries in Children
1 other identifier
interventional
60
1 country
1
Brief Summary
This study is being done to find out which medicine combination provides better pain relief after surgery in children. Children who are having surgery below the belly button (called infra-umbilical surgery) will receive general anesthesia and a type of pain-blocking injection called a caudal block. This block helps reduce pain after surgery. The study will compare two types of caudal injections: One group will receive Bupivacaine alone, a commonly used local anesthetic. The other group will receive Bupivacaine combined with Dexmedetomidine, a medicine that might help the pain relief last longer. The main question the researchers want to answer is: Does adding Dexmedetomidine to Bupivacaine increase the duration of pain relief after surgery in children? Researchers will also look at: How long it takes before the child needs the first dose of pain medicine after surgery How much pain medicine is used in the first 24 hours How long any movement problems (motor block) last Whether there are any side effects Each child will be randomly assigned (like flipping a coin) to one of the two groups. The caudal block will be done after the surgery is completed, while the child is still under anesthesia. The nurse assessing the child's pain will not know which medicine the child received. Children will be monitored for pain using a standard scoring system (FLACC scale) every few hours after surgery. If the pain score is high (7 or more), the child will receive intravenous paracetamol. Researchers will record how long the pain relief lasts, when the first pain medicine is needed, and the total amount of pain medicine used in the first 24 hours. The study aims to help doctors choose the most effective and safe method to reduce post-surgery pain in children.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_4
Started Apr 2025
Shorter than P25 for phase_4
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 27, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 26, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
July 26, 2025
CompletedFirst Submitted
Initial submission to the registry
August 7, 2025
CompletedFirst Posted
Study publicly available on registry
August 13, 2025
CompletedAugust 13, 2025
August 1, 2025
3 months
August 7, 2025
August 7, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Analgesia Duration
Duration of post-operative pain free time (hours): time from surgery to FLACC score ≥7 needing rescue analgesia
From surgery to 24-hours post operatively
Other Outcomes (1)
Analgesia Consumption
From surgery to 24-hours post operatively
Study Arms (2)
Monotherapy
ACTIVE COMPARATORBupivacaine alone
Combination therapy
EXPERIMENTALBupivacaine with Dexmedetomidine
Interventions
1 ml/kg of 0.25% Bupivacaine will be used for caudal block.
1 ml/kg of 0.25% Bupivacaine PLUS 1 μg/kg Dexmedetomidine in 1 ml Normal Saline will be used for caudal block.
Eligibility Criteria
You may qualify if:
- Elective infra-umbilical Surgeries
- ASA Status I and II
You may not qualify if:
- Chronic systemic illness (cardiovascular, pulmonary or renal disease, hepatic impairment)
- Allergy to local anesthetics
- Coagulation disorder
- Local skin infection
- Neuropathy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Allama Iqbal Teaching Hospital
Dera Ghazi Khan, Punjab Province, 32200, Pakistan
Related Publications (2)
Saadawy I, Boker A, Elshahawy MA, Almazrooa A, Melibary S, Abdellatif AA, Afifi W. Effect of dexmedetomidine on the characteristics of bupivacaine in a caudal block in pediatrics. Acta Anaesthesiol Scand. 2009 Feb;53(2):251-6. doi: 10.1111/j.1399-6576.2008.01818.x. Epub 2008 Dec 6.
PMID: 19076110BACKGROUNDGoyal V, Kubre J, Radhakrishnan K. Dexmedetomidine as an adjuvant to bupivacaine in caudal analgesia in children. Anesth Essays Res. 2016 May-Aug;10(2):227-32. doi: 10.4103/0259-1162.174468.
PMID: 27212752BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Syed A Abbas Naqvi, FCPS
Allama Iqbal Teaching Hospital Dera Ghazi Khan
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
August 7, 2025
First Posted
August 13, 2025
Study Start
April 27, 2025
Primary Completion
July 26, 2025
Study Completion
July 26, 2025
Last Updated
August 13, 2025
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will not share